An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications

Arsenic trioxide is a first-line treatment drug for acute promyelocytic leukemia, which is also effective for other kinds of leukemia. Its side effects, however, limit its clinical application, especially for patients with complex leukemia symptoms. Combination therapy can effectively alleviate thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yanan, Shen, Xiuyun, Zhi, Fengnan, Wen, Zhengchao, Gao, Yang, Xu, Juan, Yang, Baofeng, Bai, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374529/
https://www.ncbi.nlm.nih.gov/pubmed/37500645
http://dx.doi.org/10.1038/s41420-023-01558-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374529/
https://www.ncbi.nlm.nih.gov/pubmed/37500645
http://dx.doi.org/10.1038/s41420-023-01558-z

Ejemplares similares